Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

A new class of GABA receptor ligands claimed by Neurogen

Feb. 4, 1997

NOS inhibitors described by JT

Feb. 3, 1997

Neurocrine Bioscience's CRF antagonists for stress-related disorders

Feb. 3, 1997

New CNS agents with 5-HT2C-antagonist activity from Fujisawa

Feb. 3, 1997

Teva generic approved

Jan. 31, 1997

CP-0840: Dual-action bradykinin antagonist/mu-opioid agonist from Cortech

Jan. 31, 1997

New MMP inhibitors reported by Warner-Lambert

Jan. 31, 1997

Potent NK1 antagonist reported by Servier

Jan. 30, 1997

Meperidine generic approved

Jan. 30, 1997

Candidate compound identified in Pharmacopeia/Berlex collaboration

Jan. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...